Retrospective Database Analysis of the Clinical and Economic Outcomes Associated with Disruptive Surgical Bleeding
Open Access
- 1 October 2025
- journal article
- research article
- Published by Taylor & Francis in ClinicoEconomics and Outcomes Research
- Vol. ume 17, 705-716
Abstract
Background: This study evaluated the clinical and economic outcomes associated with disruptive surgical bleeding (ie, hemorrhage/hematoma that complicates a procedure despite the use of hemostatic agents) among patients with bariatric, colorectal, spine, total hip arthroplasty (THA), and total knee arthroplasty (TKA) surgery. Methods: Premier Healthcare Database patients aged ≥ 18 with one of the five procedures and hemostatic agent use between January 1-December 31, 2019, were included. Clinical and economic outcomes (ie, operating room time, 90-day all-cause inpatient readmission, in-hospital mortality, intensive care unit [ICU] admission/duration, ventilator use, hospital costs, and length of stay [LOS]) were compared between patients with and without disruptive surgical bleeding. Multivariable analyses adjusted for differences in baseline characteristics. Results: Among 119,994 patients meeting inclusion criteria, 10.8% had disruptive surgical bleeding despite the use of hemostatic agents (bariatric surgery 5.4%, colorectal surgery 20.0%, spine surgery 11.0%, THA 11.5%, TKA 5.6%). Disruptive bleeding was associated with significantly longer operating room times for bariatric, colorectal, and spine surgery (incremental increases 42.3– 62.4 minutes; p≤ 0.001), increased 90-day all-cause readmission risks for bariatric and spine surgery (incremental absolute risk increases 4.1% bariatric, 0.7% spine; both p=0.011), and increased inpatient mortality risk for all procedures except TKA (incremental absolute risk increases 0.2– 55.0%; p≤ 0.001). ICU admission risks were increased for all procedures except TKA (incremental absolute risk increases 3.0– 21.4%; p≤ 0.05), and ICU days were increased for bariatric, colorectal, and spine surgery (incremental increases 0.8– 2.8 days; p≤ 0.001). Risks for ventilator use were higher for all procedures except THA (incremental absolute risk increases 3.5– 25.2%; p≤ 0.05). Disruptive bleeding increased hospital costs (incremental increases $3,377–$23,346; p≤ 0.05) and LOS (incremental increases 1.0– 4.9 days; p≤ 0.05) for all five procedures. Conclusion: The clinical and economic burden of disruptive bleeding despite hemostatic agent use among patients with bariatric, colorectal, spine, THA, and TKA surgery was substantial, highlighting the need for improved surgical bleeding interventions.Keywords
This publication has 23 references indexed in Scilit:
- Uptake and survival effects of minimally invasive surgery for lung cancer: A population-based studyEuropean Journal of Surgical Oncology, 2021
- Comparison of open and minimally invasive approaches to colon cancer resection in compliance with 12 regional lymph node harvest quality measureJournal of Surgical Oncology, 2021
- Evaluating the Regional Uptake of Minimally Invasive Colorectal Surgery: a Report from the Surgical Care Outcomes Assessment ProgramJournal of Gastrointestinal Surgery, 2020
- Effects of Obesity Surgery on Blood Coagulation and Fibrinolysis: A Literature ReviewThrombosis and Haemostasis, 2020
- An Assessment of Bleeding Complications Necessitating Blood Transfusion across Inpatient Plastic Surgery Procedures: A Nationwide Analysis Using the National Surgical Quality Improvement Program DatabasePlastic and Reconstructive Surgery, 2019
- Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug DevelopmentClinical Pharmacology & Therapeutics, 2011
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2010
- Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative DataMedical Care, 2005
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987